Optimizing non-statin cholesterol medicines for people with ASCVD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational project will identify about 1,000 adults with documented clinical ASCVD from CommUnityCare records. Clinical pharmacists and pharmacy interns will contact participants by phone, review medications and recent lipid panels, coordinate follow-up (including local fasting labs if needed), and recommend non-statin therapy changes following current AHA/ACC guidance. Medication changes and counseling are delivered as part of routine clinical pharmacy care, and the team will collect data on visits, medicines, and LDL levels for six months. Follow-up may occur in-person or via telehealth and uses standard-of-care workflows at CommUnityCare.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients (\>18 years) who have seen a CommUnityCare provider in the previous 12 months at time of enrollment, who have a documented history of clinical ASCVD, and are not achieving LDL targets (either \<55 or \<70 mg/dL based on risk factors)

Exclusion Criteria:

* Patients will be excluded if they do not have a clearly documented history clinical ASCVD, are already achieving LDL targets (either \<55 or \<70 mg/dL based on risk factors), having cholesterol managed by outside provider (e.g. outside cardiologist/lipid specialist), current pregnancy, have not seen a CUC provider in the previous 12 months, or otherwise do not qualify for clinical pharmacy intervention

Where it's running

• CommUnityCare Health Centers
  Austin, Texas, United States Recruiting

Study contacts

• Study coordinator: Morgan Stewart, PharmD
• Email: morgan.stewart@austin.utexas.edu
• Phone: 5129789096

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ABP-745 to reduce atherosclerotic plaque in people with ASCVD

  This trial will test whether ABP-745 reduces atherosclerotic plaque over 52 weeks in adults (18–75) with ASCVD who are already taking oral lipid-lowering therapy.

  Recruiting Phase 2 Atom Therapeutics Co., Ltd · Beverly Hills, California and 32 other locations · NCT07303777

• Blocking IL-1β to reduce artery inflammation in people with coronary artery disease, including those with TET2 clonal hematopoiesis

  This trial will see if canakinumab, a drug that blocks IL‑1β, reduces artery inflammation in adults with prior heart attack or coronary stents, some of whom have TET2 clonal hematopoiesis.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT06691217

• Functional electrical stimulation plus shoulder exercises for older adults with rotator cuff pain

  In older adults with rotator cuff–related shoulder pain, this study tests whether adding functional electrical stimulation to a shoulder exercise program improves muscle coordination and reduces impingement compared with exercises alone.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07886827

• Gastric-focused ultrasound to see if it changes stomach activity and symptoms

  This study tests whether noninvasive stomach-focused ultrasound can alter post-meal stomach electrical activity and symptoms in adults with gastroparesis or delayed gastric emptying, using a sham control in a crossover design.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07851727

• The GLOW Program: GLP-1 and Lifestyle for Wellness

  This study tests whether a 30-day WILD 5 Wellness lifestyle program can improve physical and emotional well-being in adults already taking a GLP-1 or GLP-1/GIP medication.

  Recruiting University of Texas at Austin · The Colony, Texas · NCT07760896

• Music-4-MS: A 12-week music-based program to support thinking skills in people with MS

  A 12-week music-based program is tested to see if it helps cognitive function and mood in people living with multiple sclerosis.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07759115

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.